GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: EXPLORING THEIR IMPACT ON DIABETES, OBESITY, AND CARDIOVASCULAR HEALTH THROUGH A COMPREHENSIVE LITERATURE REVIEW